Posted by Michael Wonder on 05 Feb 2020
FDA takes significant step in coronavirus response efforts, issues emergency use authorisation for the first 2019 novel coronavirus diagnostic
4 February 2020 - Critical milestone reached in response to this outbreak.
Today, the U.S Food and Drug Administration issued an emergency use authorisation to enable emergency use of the Centers for Disease Control and Prevention’s (CDC) 2019-nCoV Real-Time RT-PCR Diagnostic Panel.
To date, this test has been limited to use at CDC laboratories; today’s authorisation allows the use of the test at any CDC-qualified lab across the country.
